The PRG4 gene gives joints a slippery coating called lubricin, which helps bones glide smoothly and protects cartilage during movement. This gene helps your body reduce friction in joints, tendons, and other moving tissues. When the PRG4 gene does not work properly, people can develop a rare inherited condition with joint swelling, stiff or bent fingers, hip changes, and sometimes irritation of the lining around the heart. These problems are mainly linked to poor joint lubrication, not the usual joint inflammation seen in common forms of arthritis.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage activities throughout the body. Some genes provide the directions for building proteins, which do much of the cell’s everyday work. Others are used mainly to regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you react to food, stress, or medicines. More on this topic is available in the LearnHub.
Overview
PRG4Gene function
What if the gene works
The PRG4 gene helps the body make lubricin, a slippery protein that coats joint surfaces. This helps joints move smoothly and reduces rubbing and wear in cartilage and some tendon tissues.
Risk
What if the gene does not work
Variants in the PRG4 gene can reduce joint lubrication, leading to stiffness and limited movement, often with finger or hip changes; some people also develop pericarditis. Milder and severe variants can influence when symptoms start and how pronounced they are.
Treatment
What does that mean for your treatment
No PRG4-specific treatment or drug choice is currently established for people with pathogenic variants in the PRG4 gene. The PRG4 gene is being studied as a treatment target in joint disease, including lubricin replacement, but this remains investigational.
Conditions associated with PRG4
Gene function
What if the gene works
Smooth joint motion depends in part on the PRG4 gene. It helps your body make lubricin, a slippery coating protein found on cartilage and in joint fluid. This protein lets joint surfaces glide with less friction during walking, bending, and other daily movement.
The PRG4 gene helps make lubricin, which coats cartilage with a slippery layer. This lowers friction where bones meet, so joints can glide more smoothly during everyday movement.
Lubricin also works like a nonstick coating on the joint lining. It helps keep cells and proteins from clinging to cartilage, which supports a smooth surface for motion.
By reducing rubbing at the surface, this protein helps limit routine wear from repeated movement. That is part of how the PRG4 gene helps joints move smoothly over time.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
The way variants in the PRG4 gene affect lubricin function depends on the change: some make the protein unstable, shortened, or hard for cells to release onto joint surfaces. Milder variants may leave some protein activity, while more severe variants can result in little or no usable lubricin. In PRG4-related CACP, that often goes along with earlier or more marked joint and tissue features, although the pattern can vary.
How variants are linked to conditions
Pathogenic variants in the PRG4 gene cause camptodactyly arthropathy coxa vara pericarditis syndrome, often called CACP syndrome. This rare inherited condition is one of the clearest examples of PRG4 gene variants linked to joint and hip problems, with long lasting joint swelling, bent fingers present from early life, hip shape changes, and sometimes inflammation around the heart. These findings reflect a confirmed genetic diagnosis rather than a risk trend.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors play a role. In some situations, however, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the PRG4 gene. In families with a PRG4-related condition, risk is mainly shaped by the inherited gene change itself, and a doctor or genetic counselor can help explain what that means for you or your family.
Inheritance of PRG4 variants
PRG4-related conditions follow an autosomal recessive inheritance pattern. This means a person usually inherits one PRG4 variant from each parent, and parents who each carry one variant are often unaffected themselves. For each pregnancy, two carrier parents have a 25% chance of having a child with the condition, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no inherited PRG4 variant. In practical terms, the PRG4 inheritance pattern often becomes clear only after a child is diagnosed and other family members consider carrier testing.
What does my PRG4 result mean for my family?
For PRG4, family implications are usually discussed in the context of a recessive condition. This often means parents can be healthy carriers, while brothers and sisters may also be affected or may carry the same gene change without symptoms. Children of someone with a PRG4-related condition will usually be carriers unless the other parent also carries a PRG4 change.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked to a condition involving the PRG4 gene, a lab can do genetic testing for PRG4 variants using a blood sample or saliva. The lab reads the PRG4 gene’s DNA sequence, and sometimes checks for missing or extra pieces, to show whether a relevant variant was found.
When should I consider getting a genetic test?
Consider PRG4 testing if someone has finger contractures from childhood, large painless swollen joints, hip changes, or repeated fluid around the heart, especially if these run in the family. It can help confirm a rare inherited condition that affects joint lubrication and movement.
A genetic result is only one part of your health story
A genetic test result can provide meaningful insight, but how much it explains depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines, so the same treatment may work a bit differently from one person to another. These differences can change how quickly a drug is broken down or how strongly the body responds to it, which can influence how well it works and how sensitive someone is to side effects. This is a common part of normal human variation and helps explain why medication response is not always the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way people respond to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more tailored to the individual. More detail on this topic is available in the LearnHub.
Drugs influenced by the PRG4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about medicines, side effects, or your overall health are best discussed with your doctor.
History
Research on the PRG4 gene grew out of earlier studies of a slippery joint fluid protein called lubricin, which was described before the gene itself was identified. In the 1990s, scientists linked lubricin to the surface of cartilage and to the lining of joints, helping connect a physical substance in the body to a specific genetic source. Building on this early work, scientists uncovered more about the gene when families with an inherited joint condition, now called CACP syndrome, were found to carry PRG4 variants. That discovery helped explain why some children developed joint swelling and stiffness without the usual signs of inflammation. Later studies showed that the same gene was active in several tissues involved in smooth movement. This history made PRG4 an important part of research on joint biology and inherited joint conditions.